Acxp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Acurx Pharmaceuticals (NASDAQ:ACXP – Get Free Report) and Gain Therapeutics (NASDAQ:GANX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 11.3% of Acurx […]

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 10,100 shares, an increase of 50.7% from the September 15th total of 6,700 shares. Currently, 0.1% of the company’s shares are sold short. […]

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 6,700 shares, a drop of 51.1% from the August 31st total of 13,700 shares. Based on an average daily volume of 35,000 shares, the days-to-cover ratio […]

Acurx Pharmaceuticals (NASDAQ:ACXP – Get Free Report) and vTv Therapeutics (NASDAQ:VTVT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership. Analyst Recommendations This is a summary of […]

Acurx Pharmaceuticals (NASDAQ:ACXP – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.01, MarketWatch Earnings reports. During the same quarter last year, the business earned ($0.26) earnings per share. Acurx Pharmaceuticals Stock Down 4.2 % Acurx Pharmaceuticals stock […]